Safety and Efficacy of Tocilizumab for the Treatment of Rheumatoid Arthritis
Because of the pathological role of IL-6 in rheumatoid arthritis (RA), tocilizumab (TCZ), a humanized anti-IL-6 receptor monoclonal antibody, was expected to improve inflammation and joint destruction of RA. Indeed, randomized clinical trials demonstrated the clinical efficacy of TCZ as monotherapy...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Language: | English |
| Published: |
2012
|
| Online Access: | https://doi.org/10.4137/cmamd.s7371 https://journals.sagepub.com/doi/pdf/10.4137/CMAMD.S7371 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|